The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies

[1]  S. McQuaid,et al.  Upregulation of ADAM-17 expression in active lesions in multiple sclerosis , 2006, Multiple sclerosis.

[2]  H. Hartung,et al.  Tumor necrosis factor‐α‐converting enzyme is expressed in the inflamed peripheral nervous system , 2005, Journal of the peripheral nervous system : JPNS.

[3]  F. Turkheimer,et al.  A need to clarify the role of apolipoprotein E in peripheral nerve injury and repair , 2005, Journal of the peripheral nervous system : JPNS.

[4]  Reinhard Hohlfeld,et al.  Immunobiology of muscle: advances in understanding an immunological microenvironment. , 2005, Trends in immunology.

[5]  M. Woodroofe,et al.  ADAM-17 and TIMP3 protein and mRNA expression in spinal cord white matter of rats with acute experimental autoimmune encephalomyelitis , 2005, Journal of Neuroimmunology.

[6]  Lance C Bridges,et al.  ADAM-Integrin Interactions: potential integrin regulated ectodomain shedding activity. , 2005, Current pharmaceutical design.

[7]  K. Horiuchi,et al.  Metalloprotease‐disintegrin ADAM8: Expression analysis and targeted deletion in mice , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[8]  F. Authier,et al.  ADAM12 and α9β1 Integrin Are Instrumental in Human Myogenic Cell Differentiation , 2004 .

[9]  C. Blobel,et al.  Evaluation of the Contribution of Different ADAMs to Tumor Necrosis Factor α (TNFα) Shedding and of the Function of the TNFα Ectodomain in Ensuring Selective Stimulated Shedding by the TNFα Convertase (TACE/ADAM17)* , 2004, Journal of Biological Chemistry.

[10]  M. Dalakas.  From canine to man: On antibodies, macrophages, and dendritic cells in inflammatory myopathies , 2004, Muscle & nerve.

[11]  S. Rose-John,et al.  The Transmembrane CXC-Chemokine Ligand 16 Is Induced by IFN-γ and TNF-α and Shed by the Activity of the Disintegrin-Like Metalloproteinase ADAM10 1 , 2004, The Journal of Immunology.

[12]  Feras Hawari,et al.  Shedding of the Type II IL-1 Decoy Receptor Requires a Multifunctional Aminopeptidase, Aminopeptidase Regulator of TNF Receptor Type 1 Shedding , 2003, The Journal of Immunology.

[13]  G. Rogler,et al.  Inverse regulation of the ADAM‐family members, decysin and MADDAM/ADAM19 during monocyte differentiation , 2003, Immunology.

[14]  Peter Friedl,et al.  Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. , 2003, Blood.

[15]  R. Hohlfeld,et al.  Polymyositis and dermatomyositis , 2003, The Lancet.

[16]  H. Hartung,et al.  ADAM‐10 and ADAM‐17 in the inflamed human CNS , 2003, Glia.

[17]  M. Weller,et al.  Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies. , 2003, Brain : a journal of neurology.

[18]  G. Sobue,et al.  Expression of tumor necrosis factor-α in regenerating muscle fibers in inflammatory and non-inflammatory myopathies , 2003, Acta Neuropathologica.

[19]  P. Slocombe,et al.  The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs , 2002, FEBS letters.

[20]  O. Hurtado,et al.  TACE/ADAM17–TNF-α Pathway in Rat Cortical Cultures after Exposure to Oxygen–Glucose Deprivation or Glutamate , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  B. Schoser,et al.  Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers , 2002, Acta neurologica Scandinavica.

[22]  Y. Ito,et al.  Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes. , 2001, Cellular immunology.

[23]  M. Woodroofe,et al.  Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS , 2001, Glia.

[24]  H P Hartung,et al.  Expression of specific matrix metalloproteinases in inflammatory myopathies. , 2001, Brain : a journal of neurology.

[25]  J. Peschon,et al.  TNF-α-Converting Enzyme Cleaves the Macrophage Colony-Stimulating Factor Receptor in Macrophages Undergoing Activation1 , 2001, The Journal of Immunology.

[26]  G. Sobue,et al.  Tumor necrosis factor-α expression in muscles of polymyositis and dermatomyositis , 2000, Acta Neuropathologica.

[27]  A Cumano,et al.  A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. , 2000, Molecular cell.

[28]  P. Primakoff,et al.  The ADAM gene family: surface proteins with adhesion and protease activity. , 2000, Trends in genetics : TIG.

[29]  M. Dalakas,et al.  Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies , 2000, Neurology.

[30]  C. Blobel,et al.  Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. , 1999, Journal of cell science.

[31]  S. Dimauro,et al.  Inclusion body myositis and myopathies , 1995, Annals of neurology.

[32]  Y. Nabeshima,et al.  A metalloprotease-disintegrin participating in myoblast fusion , 1995, Nature.

[33]  R. Ezzell,et al.  Induction of Heparin-binding EGF-like Growth Factor Expression during Myogenesis , 1995, The Journal of Biological Chemistry.

[34]  M. Dalakas.  Polymyositis, dermatomyositis and inclusion-body myositis. , 1991, The New England journal of medicine.

[35]  S. Yamamoto,et al.  Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. , 1990, International immunology.

[36]  J. Dichgans,et al.  The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy. , 2003, Brain : a journal of neurology.